Yon bandi ki touye 40 moun avili kek gro chèf nan leta a ki ba li zam pou'l fe vye zak li yo
Yon bandi ki touye 40 moun avili kek gro chèf nan leta a ki ba li zam pou'l opere
Immunotherapy
Immunotherapy is a promising cancer treatment only available to mesothelioma patients through clinical trials. Checkpoint inhibitors, such as pembrolizumab (Keytruda) and avelumab (Bavencio), have shown encouraging results in multicenter trials testing the drugs in combination with surgery and chemotherapy regimens. In May 2017, the U.S. Food and Drug Administration approved pembrolizumab as a first-line treatment of metastatic non-small cell lung cancer, making approval for mesothelioma a possibility in the near future.
53
mesothelioma clinical trials active or recruiting patients worldwide since 2016
53
mesothelioma clinical trials active or recruiting patients worldwide since 2016
Commentaires
Enregistrer un commentaire